Clinical Trials

Can Hyperbaric Oxygen Help or Hinder Glioblastoma Therapy?
Tech & Innovation Can Hyperbaric Oxygen Help or Hinder Glioblastoma Therapy?

Oxygen can sharpen the sword or feed the fire in glioblastoma therapy, and hyperbaric dosing, timing, and biology together decide which edge cuts and whether treatment harms or helps. This research summary examines how hyperbaric oxygen therapy (HBOT) might both strengthen and undermine standard

Do Ultra-Processed Foods Harm Us—or Their Nutrients?
Research & Development Do Ultra-Processed Foods Harm Us—or Their Nutrients?

The choice happens in a blink—flavored yogurt cup or plain yogurt with a drizzle of maple syrup—yet the metabolic ripples from that small moment could touch cholesterol, blood pressure, and insulin sensitivity before the month is out, and for millions such split-second picks may shape a decade of

Could Manganese Contrast Replace Gadolinium in MRI?
Management & Regulatory Could Manganese Contrast Replace Gadolinium in MRI?

Growing strain on MRI services collided with sharpening concerns over safety, supply, and sustainability, forcing radiology to rethink the chemistry behind contrast enhancement at scale, where about a third of scans depend on it for clarity that shapes life-changing decisions. That collision set

Can miR-181d Revolutionize Glioblastoma Treatment?
Research & Development Can miR-181d Revolutionize Glioblastoma Treatment?

The diagnostic weight of Glioblastoma Multiforme has remained largely unchanged for decades, despite the rapid acceleration of genetic sequencing and molecular mapping in other oncology sectors. This malignancy represents the primary challenge in adult oncology due to its infiltrating nature and

Atomic Map of Vibrio Bacteria Helps Disarm Deadly Infections
Research & Development Atomic Map of Vibrio Bacteria Helps Disarm Deadly Infections

The warming of coastal waters along the Atlantic and Mediterranean has accelerated the proliferation of Vibrio bacteria, creating an urgent public health crisis that demands immediate scientific intervention. As these pathogens thrive in rising temperatures, traditional medical approaches find

Can Risk-Based Oversight Secure AI in Clinical Research?
Research & Development Can Risk-Based Oversight Secure AI in Clinical Research?

The rapid proliferation of computational intelligence in pharmaceutical development has reached a critical juncture where traditional manual oversight methods are struggling to keep pace with the speed of machine learning integration. On April 20, 2026, Advarra unveiled a comprehensive framework

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later